Dschietzig, Thomas

First clinical experience with intravenous recombinant human relaxin in compensated heart failure. [electronic resource] - Annals of the New York Academy of Sciences Apr 2009 - 387-92 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1749-6632

10.1111/j.1749-6632.2008.03819.x doi


Drug Administration Schedule
Heart Failure--drug therapy
Humans
Infusions, Intravenous
Recombinant Proteins--administration & dosage
Relaxin--administration & dosage
Treatment Outcome